LR Health & Beauty strengthens its management team with Martin Lipp as new Chief Financial Officer (CFO) Ahlen, 7 September 2026 – The LR Health & Beauty GmbH, Europe’s leading social commerce company for high-quality nutritional supplements and beauty products, is strengthening its management team: effective 7 September 2026, Martin Lipp  [ … ]

LR Health & Beauty SE publishes figures for the first half of 2026 H1 2026 sales reached EUR 118.6 million, with normalized EBITDA of EUR 8.7 million In the transformation year 2026, LR systematically advances strategic initiatives to position the organization for the future Business Days in September boost international partner community a [ … ]

LR Health & Beauty SE publishes final 2025 annual report and continues to execute its strategic initiatives Preliminary FY 2025 sales and EBITDA confirmed Solid financial footing provides scope to consistently advance strategic initiatives aimed at optimizing production, logistics and sales Ahlen, 4 August 2026 – LR Health & Beauty SE, E [ … ]

LR HEALTH & BEAUTY SE INITIATES A WRITTEN PROCEDURE UNDER ITS OUTSTANDING BOND LOAN IN RESPECT OF A COMPREHENSIVE RESTRUCTURING, PUBLISHES A PROSPECTUS FOR SUBSCRIPTION OF BONDS AND INVITES BONDHOLDERS TO SUBSCRIBE FOR SHARES IN ITS NEW PARENT COMPANY Ahlen, 19 May 2026 – LR Health & Beauty SE (the “Company”) has today decided to initiate  [ … ]

LR Health & Beauty SE announces successful conclusion of the Written Procedure initiated on 6 March 2026 under the 2024/2028 Bonds and issuance of Super Senior Bonds Ahlen, 24 March 2026 – On 6 March 2026, LR Health & Beauty SE (the “Company”) initiated a written procedure (the “Written Procedure”) under the terms and conditions for the Co [ … ]

Disclosure of an inside information according to Art. 17 of the Regulation (EU) No. 596/2014 (Market Abuse Regulation – MAR) LR HEALTH & BEAUTY SE INITIATES A WRITTEN PROCEDURE UNDER ITS OUTSTANDING BOND LOAN IN RESPECT OF TEMPORARY WAIVERS AND SUPER SENIOR BRIDGE FINANCING Ahlen, 6 March 2026 – LR Health & Beauty SE (the “Company”) has,  [ … ]

LR HEALTH & BEAUTY SE REACHES AN AGREEMENT WITH BONDHOLDERS AND SHAREHOLDER REGARDING A COMPREHENSIVE RESTRUCTURING OF THE 2024/2028 BOND – EUR 20 MILLION IN NEW CAPITAL AND SIGNIFICANTLY REDUCED DEBT STRUCTURE Ahlen, 11 February 2026 – Today, LR Health & Beauty SE (the “Company”) reached an agreement with bondholders representing more tha [ … ]

Disclosure of an inside information according to Art. 17 of the Regulation (EU) No. 596/2014 (Market Abuse Regulation – MAR)LR HEALTH & BEAUTY SE: PRELIMINARY RESULTS FOR FINANCIAL YEAR 2025 / TARGETED EQUITY CONTRIBUTION / TARGETED RESTRUCTURING OF THE 2024/2028 BONDS Ahlen, 23 January 2026 – Today, based on the preliminary financial results  [ … ]